Vertex offers ‘portfolio approach’ to secure access to CF meds
Vertex has presented NHS England with an “innovative long-term framework proposal” that hopes to secure access for all eligible patients to its current and future portfolio of cystic fibrosis (CF) medicines.
Read More
